期刊文献+

血清生长分化因子-15与先天性心脏病患儿心功能的关系及其对心力衰竭的诊断价值 被引量:5

Plasma concentration of growth-differentiation factor-15 in children with congenital heart disease: relation ship to heart function and diagnostic value in heart failure
原文传递
导出
摘要 目的探讨生长分化因子-15(GDF-15)与先天性心脏病患儿心功能的关系及其对心力衰竭的诊断价值。方法 2011年3月至2012年5月成都市妇女儿童中心医院就诊的先天性心脏病患儿97例,依据改良Ross评分法分为心力衰竭组(71例)和无心力衰竭组(26例)。ELISA法检测两组血清GDF-15和B型脑钠肽前体(NT-proBNP)水平,超声心动图检测左室射血分数(LVEF)。采用Spearman相关分析对GDF-15与改良Ross评分、LVEF及NT-proBNP的相关关系进行分析。绘制ROC曲线并计算GDF-15曲线下面积及诊断心力衰竭的截断值。结果心力衰竭组患儿血清GDF-15和NT-proBNP水平较无心力衰竭组显著增高,LVEF明显降低,差异有统计学意义(P<0.01)。血清GDF-15水平与改良Ross评分及血清NT-proBNP水平呈正相关(分别r=0.705和0.810,P<0.01),与LVEF呈负相关(r=-0.421,P<0.01)。GDF-15诊断心力衰竭的ROC曲线下面积为0.757,当GDF-15的诊断界值为1306 ng/L,敏感性和特异性分别为68.8%和71.2%。结论先天性心脏病合并心力衰竭患儿血清GDF-15明显升高,血清GDF-15水平与先天性心脏病患儿心功能、LVEF及NT-proBNP水平均有不同程度的相关关系;GDF-15可能成为诊断小儿先天性心脏病合并心力衰竭的一项检测指标。 Objective To study the correlation between growth differentiation factor-15 (GDF-15) and cardiac function in pediatric patients with congenital heart disease, and the diagnositic value of GDF-15 in heart failure (HF). Methods From March 2011 to May 2012, 97 pediatric patients with congenital heart disease (CHD) who consecutively attended Chengdu Women's & Children's Central Hospital were enrolled in the study and assigned to HF (patients with heart failure, n =71 ) and Non-HF(patients without heart failure, n =26) groups. HF was defined as patients presenting with modified Ross score≥ 3. Plasma concentrations of GDF-15 and NT-proBNP were determined using ELISA. Left ventricular ejection fraction(LVEF) was tested by echocardiography. The correlation between GDF-15 and modified Ross score, LVEF and NT-proBNP was evaluated with Spearman's analysis. The area under the receiver-operating characteristic (ROC) curve for GDF-15 was examined, and the cut-off concentration of GDF-15 for diagnosing HF was detected. Results The HF group demonstrated higher levels of GDF-15 and NT-proBNP, and a lower LVEF level (P 〈 O. 01 ) than the Non- HF group. Plasma GDF-15 level was positively correlated with modified Ross score and plasma NT-proBNP comcentration (r =0. 705, r =0. 810 respectively; P 〈0.01 ), and negatively correlated with LVEF(r = -0. 391, P 〈0.01 ). According to ROC analysis, the AUC of GDF-15 for detection of HF was 0. 757. Sensitivity and specificity was 68.8% and 71.2% respectively for the cut-off value of 1306 ng/mL. Conclusions Plasma GDF-15 levels are significantly elevated in children with HF induced by CHD. Plasma GDF-15 levels are related to cardiac function, LVEF and plasma concentration of NTproBNP. GDF-15 may potentially indicate HF in pediatric patients with CHD.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2013年第2期95-98,共4页 Chinese Journal of Contemporary Pediatrics
关键词 生长分化因子-15 先天性心脏病 心力衰竭 B型脑钠肽前体 左室射血分数 儿童 Growth differentiation factor-15 Congenital heart disease Heart failure NT-proBNP Left ventricular ejection fraction Child
  • 相关文献

参考文献12

  • 1Dominguez-Rodriguez A,Abreu-Gonzalez P,Avanzas P. Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction[J].American Journal of Cardiology,2011,(07):955-958.
  • 2Dinh W,Futh R,Lankisch M,Hess G Zdunek D Scheffold T. Growth-differentiation factor-15:a novel biomarker in patients with diastolic dysfunction[J].Arquivos Brasileiros de Cardiologia,2011,(01):65-75.
  • 3Wang F,Guo Y,Yu H,Zheng L Mi L Gao W. Growth differentiation factor 15 in different stages of heart failure:potential screening implications[J].Biomarkers:Biochemical Indicators of Exposure,Response Andsusceptibility to Chemicals,2010,(08):671-676.
  • 4Anand IS,Kempf T,Rector TS,Tapken H Allhoff T Jantzen F. Serial measurement of growth-differentiation factor-15 in heart failure:relation to disease severity and prognosis in the Valsartan Heart Failure Trial[J].Circulation,2010,(14):1387-1395.
  • 5陈树宝,李万镇,马沛然,钱永如,宁寿葆.小儿心力衰竭诊断与治疗建议[J].中华儿科杂志,2006,44(10):753-757. 被引量:110
  • 6Laer S,Mir TS,Behn F,Eiselt M Scholz H Venzke A. Carvedilol therapy in pediatric patients with congestive heart failure:a study investigating clinical and pharmacokinetic parameters[J].American Heart Journal,2002,(05):916-922.
  • 7KempfT,von Haehling S,Peter T,AllhoffT Cicoira M Doehner W. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure[J].Journal of the American College of Cardiology,2007,(ll):1054-1060.
  • 8Norozi K,Buchhom R,Yasin A,Geyer S Binder L Seabrook JA. Growth differentiation factor 15:an additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects[J].American Heart Journal,2011,(01):131-135.
  • 9Ross RD. Grading the graders of congestive heart failure in children[J].Journal of Pediatrics,2001,(05):618-620.
  • 10张鹤,李玖军.先天性心脏病患儿血浆脑钠肽水平与左心功能的关系[J].中国当代儿科杂志,2012,14(1):42-44. 被引量:13

二级参考文献17

  • 1陈新民.小儿心力衰竭诊断进展[J].实用儿科临床杂志,2006,21(18):1201-1202. 被引量:1
  • 2Braunwald E.心脏病学[M].第5版.北京:人民卫生出版社,1999:542-582.
  • 3Goto T, Takase H, Toriyama T, Sugiura T, Sato K, Ueda R, et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure [ J ]. Heart, 2003, 89 ( 11 ) : 1303-1307.
  • 4Mangat J, Carter C, Riley G, Foo Y, Burch M. The clinical utility of brain natriuretic peptide in paediatric left ventrieular failure [ J]. Eur J Heart Fail, 2009, 11 (1) : 48-52.
  • 5Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, et al. Comparative impact of multiple biomarkers and N- Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation ( HOPE ) Study [ J ]. Circulation, 2006, 114(3) : 201-208.
  • 6Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure [J]. Endocr Rev, 2003, 24(3) : 341-356.
  • 7Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction [ J ]. Circulation, 1995, 92(6) : 1558-1564.
  • 8Lim P, Monin JL, Monchi M, Garot J, Pasquet A, Hittinger L, et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide [J]. Eur Heart J, 2004, 25 (22) : 2048-2053.
  • 9Liang F, Gardner DG. Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism [ J ]. J Clin Invest, 1999, 104 ( 11 ) : 1603-1612.
  • 10Felker GM, Petersen JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure[ J]. CMAJ, 2006, 175 (6) : 611-617.

共引文献120

同被引文献41

  • 1刘锦纷,丁文祥.我国小儿先天性心脏病外科诊治的发展和挑战[J].上海交通大学学报(医学版),2011,31(9):1221-1225. 被引量:10
  • 2陈树宝,李万镇,马沛然,钱永如,宁寿葆.小儿心力衰竭诊断与治疗建议[J].中华儿科杂志,2006,44(10):753-757. 被引量:110
  • 3胡亚美 江载芳 诸福棠.实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1900.
  • 4Lok SI,Winkens B,Goldschmeding R. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with nonischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support[J].European Journal of heart failure,2012,(11):1249-1256.
  • 5Koch AM,Zink S,Gl,o)ckler M. Plasma levels of B-type natriuretic peptide in patients with tetralogy of Fallot after surgical repair[J].Int J Cardio1,201 ,(02):130-134.
  • 6Bj(o)rnstad JL,Neverdal NO,Vengen OA. Alterations in circulating activin A,GDF-15,TGF-β3 and MMP-2,-3,and-9 during one year of left ventricular reverse remodelling in patients operated for severe aortic stenosis[J].European Journal of heart failure,2008,(12):1201-1207.
  • 7Baessler A,Strack C,Rousseva E. Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity[J].European Journal of heart failure,2012,(11):1240-1248.
  • 8Khan SQ,Ng K,Dhillon O. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction[J].EUROPEAN HEART JOURNAL,2009,(09):1057-1065.
  • 9Kempf T,Eden M,Strelau J. The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury[J].Cire Res,2006,(03):351-360.
  • 10Anand IS,Kempf T,Rector TS. Serial measurement of growth-differentiation factor-15 in heart failure relation to disease severity and prognosis in the valsartan heart failure trial[J].CIRCULATION,2010,(14):1387-1395.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部